Program
Program at a glance Corporate Seminar
Presidential Lecture
Deepening connections
- Chair:
- Yataro Yoshida (Takeda General Hospital)
- Speaker:
- Akifumi Takaori (Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University)
Special Symposium
Special Symposium1
- Chair:
- Akifumi Takaori (Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University)
- Speaker:
- Shinya Yamanaka (Center for iPS Cell Research and Application (CiRA), Kyoto University)
Special Symposium2
Metabolic Regulation of Malignancy
- Chair:
- Akifumi Takaori (Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University)
- Speaker:
- Tak W. Mak (Princess Margaret Cancer Centre, Toronto, Canada Centre of Oncology and Immunology, University of Hong Kong)
Presidential Symposium
Retrovirus infection and hematological diseases
- Chair:
- Akifumi Takaori (Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University)
Masao Matsuoka (Kumamoto University) - Speaker:
- Jun-ichirou Yasunaga (Kumamoto University)
Keisuke Kataoka (Division of Hematology, Department of Medicine, Keio University School of Medicine)
Kenji Ishitsuka (Department of Hematology and Rheumatology, Kagoshima University)
Seiji Okada (Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection, Kumamoto University)
Kotaro Shirakawa (Kyoto University Hospital)
ASH Special Lecture
- Speaker:
- Mohandas Narla (New York Blood Center Enterprises)
EHA Special Lecture
- Speaker:
- Antonio Almeida (Hospital da luz Lisboa Universidade Católica Portuguesa)
Asian Joint Panel Discussion
Virus-associated lymphoid malignancies in Asian countries
- Chair:
- Motoko Yamaguchi (Mie University Graduate School of Medicine)
Bor-Sheng Ko (Department of Hematological Oncology, National Taiwan University Cancer Center,Taipei, Taiwan/School of Medicine, College of Medicine, National Taiwan University, Taipei,Taiwan/Department of Internal Medicine, Naitonal Taiwan University Hospital,Taipei, Taiwan/Tai-Cheng Cell Therapy Center, National Taiwan University, Taiwan) - Speaker:
- Ayako Arai (St. Marianna University School of Medicine)
Haiwen Huang (Division of Hematology the First Affiliated Hospital of Soochow University)
Ming-Han Tsai (Institute of Microbiology and Immunology, National Yang Ming Chiao Tung University)
Kitsada Wudhikarn (Faculty of Medicine, Chulalongkorn University)
Seok Jin Kim (Samsung Medical Center, Sungkyunkwan University School of Medicine)
Jina Bhattacharyya (Department of Clinical Hematology Gauhati Medical College & Hospital, Guwahati)
Shin Yeu Ong (Department of Haematology Singapore General Hospital)
Symposium
Symposium 1
Recent advances in biology and treatment of B-cell lymphoma
- Chair:
- Koji Kato (Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences)
Mamiko Sakata-Yanagimoto (University of Tsukuba) - Speaker:
- David Kurtz (Stanford University)
Mamiko Sakata-Yanagimoto (University of Tsukuba)
Franck Morschhauser (Hematology department Centre Hospitalier Universitaire de Lille)
Caron Jacobson (Dana-Farber Cancer Institute)
Symposium 2
Hemalytic Anemia -2024 update-
- Chair:
- Hideo Harigae (Department of Hematology Tohoku University Graduate School of Medicine)
Hirohito Yamazaki (Divission of Transfusion Medicine, Kanazawa University Hospital) - Speaker:
- Yasutaka Ueda (Osaka University Graduate School of Medicine)
Sigbjørn Berentsen (Department of Research and Innovation, Haugesund Hospital)
Hideho Wada (Department of Hematology, Kawasaki Medical School)
Janis L Abkowitz (University of Washington and Fred Hutch Cancer Center)
Symposium 3
Germline background of hematologic diseases
- Chair:
- Hiroyoshi Hattori (Department of Clinical Genetics, National Hospital Organization Nagoya Medical Center)
Atsushi Manabe (Hokkaido University Graduate School of Medicine) - Speaker:
- Motohiro Kato (Department of Pediatrics, the University of Tokyo)
Hideki Muramatsu (Department of Pediatrics, Nagoya University Graduate School of Medicine)
Akiko Shimamura (Boston Children's Hospital, Dana Farber Cancer Institute, Harvard Medical School)
Yoshiko Nakano (The Hospital for Sick Children)
Symposium 4
HSCT as a cell therapy: current situation and novel approach
- Chair:
- Satoshi Takahashi (Institite of medical Science, Unversity of Tokyo)
Junya Kanda (Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University) - Speaker:
- Takaaki Konuma (Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo)
Mitchell E. Horwitz (Adult Blood and Marrow Transplant Program Duke University School of Medicine)
Katy Rezvani (The University of Texas MD Anderson Cancer Center)
Daigo Hashimoto (Department of Hematology, Hokkaido University)
Kaoru Morita (Jichi Medical University)
Symposium 5
Dissection of myeloma biology by novel approaches
- Chair:
- Junya Kuroda (Kyoto Prefectural University of Medicine Graduate School of Medical Science)
Takeshi Harada (Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences) - Speaker:
- Michael Slade (Washington University School of Medicine in Saint Louis)
Bruno Paiva (Clinica Universidad de Navarra)
Hiroto Ohguchi (Kumamoto University)
Naoya Mimura (Chiba University Hospital)
Symposium 6
Recent advances in acute leukemia treatment
- Chair:
- Yoshihiro Hatta (Hematology and Rheumatology, Nihon University)
Katsuyoshi Koh (Saitama Children's Medical Center) - Speaker:
- Charles G Mullighan (St. Jude Children's Research Hospital Department of Pathology)
Akihiko Yokoyama (National Cancer Center)
Hidefumi Hiramatsu (Department of Pediatrics Kindai University, Faculty of Medicine)
Atsushi Sato (Department of Hematology and Oncology, Miyagi Children's Hospital)
Nicholas Short (Associate Professor, Department of Leukemia, The University of Texas MD Anderson Cancer Center)
Symposium 7
Ex vivo generation and expansion of hematopoietic cells
- Chair:
- Susumu Goyama (Graduate School of Frontier Sciences, The University of Tokyo)
Noboru Asada (Okayama University Hospital) - Speaker:
- Satoshi Yamazaki (Tokyo University)
Koji Eto (CiRA, KYOTO UNIVERSITY)
Mineo Kurokawa (Department of Hematology and Oncology, The University of Tokyo)
Jan Frayne (University of Bristol)
Kyle Loh (Stanford University)
Symposium 8
MPN: update 2024
- Chair:
- Akihiko Gotoh (Department of Hematology, Tokyo Medical University)
Naoto Takahashi (Akita University) - Speaker:
- Hiroki Yamaguchi (Derpatment of Hematology, Nippon Medcial School)
Terra L. Lasho (Mayo Clinic)
Keita Kirito (Department of Hematology/Oncology, University of Yamanashi)
Katsuto Takenaka (Dept of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine)
Yuka Sugimoto (Department of Hematology and Oncology, Mie University Graduate School of Medicine)
JSH-EHA Joint Symposium
Genetic diagnosis of congenital diseases on thrombosis and hemostasis
- Chair:
- Tsukasa Ohmori (Jichi Medical University)
Antonio Almeida (Hospital da luz Lisboa Universidade Católica Portuguesa) - Speaker:
- Shouichi Ohga (Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University)
Caterina Casari (Inserm UMR-S 1176 Hemostasis Inflammation Thrombosis)
Koichi Kokame (National Cerebral and Cardiovascular Center)
Johannes Oldenburg (University Clinic Bonn Institute of Experimental Haematology and Transfusion Medicine)
JSH-ASH Joint Symposium
Next generation CAR-T cell therapy
- Chair:
- Yasuyuki Arai (Kyoto University Hospital)
Mohandas Narla (New York Blood Center Enterprises) - Speaker:
- Miki Ando (Juntendo University School of Medicine)
John F. DiPersio (Washington University School of Medicine)
Reona Leo Sakemura (Mayo Clinic)
Fabiana Perna (Moffitt Cancer Center)
EHA-JSH Travel Grant Awardee's Session in JSH2024
- Chairs:
- Atsushi Hirao (Kanazawa University, Cancer Research Institute)
Kinuko Mitani (Dokkyo Medical University)
TGP-1 Amino acid influx via LAT1 regulates iron dependency of aggressive natural killer leukemia
Ryo Yanagiya 1,2,3(RMID, Osaka Univ. Suita, Japan 1,Dept. Hematology and Oncology, Tokai University, Isehara, Japan 2,Dept. Innovative Medical Science, Tokai University, Isehara, Japan 3)
TGP-2 Role of inflammation in Waldenstrom macroglobulinemia: Insights from a multicenter study
Pierre-edouard Debureaux (Saint Louis Hospital, Paris, France)
TGP-3 Physical and functional interaction among Irf8 enhancers during dendritic cell differentiation
Takaya Yamasaki (Department of Immunology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan)
TGP-4 Patients suffering from B12 deficiency: Comparison of parenteral and peroral treatment
Bzduch Arpad (SCM Caritas Medica, Satu Mare, Romania)
TGP-5 Nociceptive nerves facilitate stem/progenitor cell homing to bone marrow by regulating microcirculation and mechanosensing
Shinya Fujita(Department of Stem Cell Biology, NCGM, Tokyo, Japan)
TGP-6 Novel designs for enhancing CAR-T therapy against multiple myeloma targeting BCMA
Jorge Illarramendi Esteban (University Hospital of Navarra, Spain)
TGP-7 Targeting patient-specific vulnerabilities in anti-apoptotic pathway combined with CXCR4 expressing CAR-T cells eliminates high-risk leukemia
Ryo Nakagawa(Department Hematology, Tohoku Univ. Hospital, Sendai, Miyagi, Japan)
TGP-8 Large Italian RWE study on optimal duration of CPX-351 treatment and best timing for transplant
Fabio Guolo (Clinic of Hematology, Department of Internal Medicine, University of Genoa, Genoa, Italy)
TGP-9 Centre effect on outcomes of allogeneic hematopoietic stem cell transplantation for B-cell acute lymphoblastic leukemia: a registry-based study in Japan
Shuhei Kurosawa 1,2 (Department of Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan 1, Division of Transfusion and Cell Therapy, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan 2)
TGP-10 Prophylaxis in hematologic malignancy patients undergoing ASCT: Cefpodoxime or levofloxacin?
Taner Tan 1,2 (Koc University Hospital, Turkey 1, Yeditepe University Hospital, Istanbul, Turkey 2)
TGP-11 Impacts of donor age and HLA disparity on survival outcomes after unrelated allo-HCT were significantly influenced by donor CMV serostatus
Shunto Kawamura 1,2 (Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan 1, Division of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan 2)
Joint session of the Japanese, German, Swiss and Austrian Societies of Hematology
Joint meeting of the Japanese, German, Swiss and Austrian Societies of Hematology Cooperative CML research
Chairs
Itaru Matsumura (Kindai University Faculty of Medicine)
Andreas Hochhaus (Universitätsklinikum Jena, Direktor der KIM II und der
Abteilung Hämatologie / Internistische Onkologie, Sprecher desUniversitätsTumorCentrums Jena, Leiter des Zentrums für Hämatologische Neoplasien (Jena, Deutschland))
Welcome
Andreas Hochhaus (Universitätsklinikum Jena, Direktor der KIM II und der Abteilung Hämatologie /Internistische Onkologie, Sprecher des UniversitätsTumorCentrums Jena, Leiter des Zentrums für Hämatologische Neoplasien (Jena, Deutschland))
Itaru Matsumura (Kindai University Faculty of Medicine)
Introduction of the Joint Annual Meeting of the German, Austrian and Swiss Societies of Hematology and Medical Oncology
Anne Angelillo-Scherrer (Universitätsklinik für Hämatologie und Hämatologisches Zentrallabor, Inselspital, Universitätsspital Bern, Ordinaria, Klinikdirektorin und Chefärztin, Stv. Leiterin Referenzzentrum Erwachsenen-Hämophilie / European Hemophilia Comprehensive Care Center (EHCCC), (Bern, Switzerland))
Introduction of the Japanese Society of Hematology
Itaru Matsumura (Kindai University Faculty of Medicine)
International Cooperation of the European Haematology Association
Antonio Almeida (Head of department at Hospital da Luz, Lisbon, Portugal)
CML epidemiology and management in Europe
Andreas Hochhaus (Universitätsklinikum Jena, Direktor der KIM II und der Abteilung Hämatologie / Internistische Onkologie, Sprecher des UniversitätsTumorCentrums Jena, Leiter des Zentrums für Hämatologische Neoplasien (Jena, Deutschland))
CML epidemiology and management in Japan
Itaru Matsumura (Kindai University Faculty of Medicine)
Translational CML research
Dominik Wolf (Direktor der Universitätsklinik für Innere Medizin V, Medizinische Universität Innsbruck (Innsbruck, Austria))
Ongoing and planned clinical trials in Japan
Naoto Takahashi (Akita univ.)